Skip to main navigation

Investor Relations

Investor Overview
Stock Information
- Stock Quote & Chart
News & Events
- News Releases
- Events
SEC Filings
Corporate Governance
Investor Resources

News Releases

News Releases

08 Nov '21

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

08 Nov '21

Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

08 Oct '21

Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

30 Sep '21

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

21 Sep '21

Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

21 Sep '21

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

12 Aug '21

Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

10 Aug '21

Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors

04 Aug '21

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

19 May '21

Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations

Pagination

First page
Previous page
Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Displaying 1 - 10 of 51

Investor Tools

Print Page
E-mail Alerts
RSS Feeds

Request E-mail Alerts

Footer Links

ABOUT US

TECHNOLOGY

PIPELINE

NEWS

CAREERS

CONTACT

© 2021 Black Diamond Therapeutics, Inc. All rights reserved.

Facebook
Twitter
LinkedIn
Google+